A case of fetal anticonvulsant syndrome with severe bilateral upper limb defect

Area of Science:

• Neurology
• Teratology
• Pharmacology

Background:

• Epilepsy treatment during pregnancy presents risks for fetal development.
• Anticonvulsant medications are commonly prescribed for women with epilepsy.
• Combined anticonvulsant therapy may increase teratogenic risks.

Observation:

• A case report details a child with severe bilateral upper limb defects.
• The child exhibited phenotypic features consistent with fetal valproate syndrome.
• Prenatal exposure involved both valproate and carbamazepine.

Findings:

• Combined prenatal exposure to valproate and carbamazepine is associated with severe limb malformations.
• The observed phenotype aligns with known fetal valproate syndrome characteristics.
• Anticonvulsant drug combinations pose a significant risk for severe birth defects.

Implications:

• Highlights the critical need for careful medication management in pregnant women with epilepsy.
• Emphasizes the teratogenic potential of specific anticonvulsant combinations.
• Suggests enhanced monitoring and counseling for women on these medications during pregnancy.